Could a blood clot drug boost brain recovery after aneurysm bleed?
NCT ID NCT07144956
First seen Oct 31, 2025 · Last updated Jun 20, 2026 · Updated 34 times
Summary
This study tests whether adding the drug cilostazol to standard care helps people recover better after a brain bleed caused by a ruptured aneurysm. About 630 adults will receive either cilostazol or a placebo for 14 days, and their recovery will be checked at 6 months. The goal is to see if this combination reduces disability and improves daily function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cilostazol (Pletal®) tablets
What this could lead to
If it works, this could point toward a better recovery for people who survive a bleeding stroke from a brain aneurysm.
What could go wrong
This is a phase 3 trial, but it is still early to know if adding cilostazol truly helps. The study is not yet recruiting, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.